Perrouin-Verbe, B <br/><br/>
[Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity].  [electronic resource] 

 -  Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie  Jun 2009 
 - 372-82 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>1166-7087 
<br/><br/><label>Standard No.: </label>10.1016/j.purol.2009.02.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Botulinum Toxins, Type A--therapeutic use<br/>Humans<br/>Injections<br/>Neuromuscular Agents--therapeutic use<br/>Urinary Bladder, Neurogenic--drug therapy